AbFero Pharmaceuticals is a privately held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload. Their therapeutic platform addresses transfusion-related iron overload (TIO) and iron accumulation associated with diseases of aging, such as age-related macular degeneration (AMD), and Parkinson’s disease. 

Biotechnology

AbFero Pharmaceuticals

Raymond J Bergeron

Jeff Harder

Steven K. Burke

AbFero Pharmaceuticals' Leadership Team includes Thomas X Neenan and 4 others.

Leadership Team

About

Team members